63411-79-0

Basic information

• Product Name: 2-PYRIDIN-4-YL-1H-IMIDAZO[4,5-C]PYRIDINE
• Synonyms: 2-PYRIDIN-4-YL-1H-IMIDAZO[4,5-C]PYRIDINE;2-(4-Pyridyl)-7-azabenziMidazole, 97%;2-pyridin-4-yl-3H-imidazo[4,5-c]pyridine
• CAS NO: 63411-79-0
• Molecular Formula: C₁₁H₈N₄
• Molecular Weight: 196.20802
• Mol File: 63411-79-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 476 °C at 760 mmHg
• Flash Point: 234.6 °C
• Appearance: /
• Density: 1.336 g/cm³
• CAS DataBase Reference: 2-PYRIDIN-4-YL-1H-IMIDAZO[4,5-C]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-PYRIDIN-4-YL-1H-IMIDAZO[4,5-C]PYRIDINE(63411-79-0)
• EPA Substance Registry System: 2-PYRIDIN-4-YL-1H-IMIDAZO[4,5-C]PYRIDINE(63411-79-0)

Safety Data

• Hazardous Substances Data: 63411-79-0(Hazardous Substances Data)

Usage

General Description

2-Pyridin-4-yl-1H-imidazo[4,5-c]pyridine is a chemical compound with the molecular formula C11H7N5. It is a heterocyclic compound that contains both imidazole and pyridine rings, making it important in medicinal chemistry as a potential pharmacophore for drug development. 2-PYRIDIN-4-YL-1H-IMIDAZO[4,5-C]PYRIDINE has been studied for its potential anti-cancer and anti-inflammatory properties, as well as its potential use as a therapeutic agent for neurological disorders. Its unique structure and potential biological activities make it a molecule of interest in the field of drug discovery and development.

Upstream product

• 108-89-4 picoline 
• 54-96-6 3,4-diaminopyridine 
• 1003-67-4 4-methylpyridine-1-oxide 
• 1681-37-4 4-amino-3-nitropyridine 
• 55-22-1 pyridine-4-carboxylic acid 
• 3731-53-1 4-(aminomethyl)pyridine 
• 13091-23-1 4-chloro-3-nitropyridine 

Relevant articles and documents

Weak interactions in imidazole-containing zinc(II)-based metal–organic frameworks

The self-assembly of the two zinc(II) metal–organic frameworks, [Zn2(L)(bdc)2]·3MeOH·4H2O}n (1, L = 2-(pyridin-4-yl)-3H-imidazo[4,5-c]pyridine, H2bdc = 1,4-benzenedicarboxylic acid) and [Zn2(L)(bdc)2]·2DMF·H2O}n (2), was achieved under mild reaction conditions. Both compounds 1 and 2 were structurally characterized by single-crystal X-ray diffraction analysis. Interestingly, the coordination modes of the ligand L in two structures are entirely different. Compounds 1 and 2 were made up of paddle wheel-shaped {Zn2(O2C)4} secondary building unit (SBU) clusters, which adopted three-dimensional structures with a pcu topology. Rich weak interactions were observed in the structures of both 1 and 2. The uncoordinated imidazole and pyridine moieties exhibited electron donor–acceptor interactions, π–π stacking, hydrogen bonding, and CH–π interactions. These interactions also facilitated the abilities of the framework to adsorb CO2 molecules. Gas adsorption studies revealed that compound 1 selectively adsorbed CO2 (131.1 cm3/g) over N2 (23.5 cm3/g) and H2 (36.5 cm3/g) at a pressure of 1 atm.

Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: From anti-pestivirus to anti-hepatitis C virus activity

A novel class of inhibitors of the hepatitis C virus [substituted 2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridines] is described. Introduction of a fluorine in position 2 of the 2-phenyl substituent of the lead anti-pestivirus compound 1 (5-[(4-bromophenyl)m

MODIFIED METHOD FOR THE SYNTHESIS OF 2-HETEROARYL-SUBSTITUTED IMIDAZOPYRIDINES AND BENZIMIDAZOLE

A method is proposed for the production of 2-heteroarylimidazopyridines and benzimidazole, based on the oxidation of o-nitroaminopyridine or o-nitroaniline and heteroaromatic compounds with an active methyl group by elemental sulfur.